Semaglutide works with your bodys natural hormones to help control appetite, reduce cravings, improve blood sugar balance , and promote gradual fat reduction
Changes from baseline in cardiovascular, metabolic, and inflammatory biomarkers among GLP-1 drug users were as follows: Triglycerides: -16.4 mg/dL LDL cholesterol: -7.3 mg/dL HbA1c: -0.3 percentage points CRP: -0.6 mg/dL ESR: -3.0 mm/hr These were all numerically greater than corresponding changes for non-users, but often the differences didn't reach statistical significance
Others may only cover Ozempic (semaglutide) or Mounjaro (tirzepatide) when prescribed for their FDA-approved use in type 2 diabetes, not specifically for weight loss
AL: Data collection, assistance in data interpretation
GLP-1 medications significantly delay gastric emptying, meaning food stays in your stomach and upper GI tract longer than it normally would